EIF2AK2 and juvenile Huntington disease: (1) PKR level and post-translation modifications are excellent biomarkers for neurodegenerative diseases (e.g., AD, dementia, Parkinson’s disease, Huntington’s disease, and prion disease) and cancer (Figure 4, based on open source data).